Case Study 9 Gerd Surgery

1.

A Gallup survey on heartburn across America. Princeton, NJ: The Gallup Organization, Inc., 1988 .

2.

Locke G R III, Talley N J, Fett S L, Zinsmeister A R, Melton J III. Prevalence and clinical spectrum of gastroesophageal reflux: A population-based study in Olmsted County, Minnesota. Gastroenterlogy. 1997;112:1448–1456. [PubMed: 9136821]

3.

Richter J. Do we know the cause of reflux disease? Eur J Gastroenterol Hepatol. 1999;11(Suppl 1):S3–9. [PubMed: 10443906]

4.

Fein M, Ritter M P, DeMeester T R. et al. Role of the lower esophageal sphincter and hiatal hernia in the pathogenesis of gastroesophageal reflux disease. J Gastrointest Surg. 1999;3:406–410. [PubMed: 10482693]

5.

O'Sullivan G C, DeMeester T R, Joelsson B E, Smith R B, Blough R R, Johnson L F, Skinner D B. Interaction of lower esophageal sphincter pressure and length of sphincter in the abdomen as determinants of gastroesophageal competence. Am J Surg. 1982;143:40–7. [PubMed: 7053654]

6.

Bonavina L, Evander A, DeMeester T R, Walther B, Cheng S C, Palazzo L, Concannon Length of the distal esophageal sphincter and competency of the cardia. Am J Surg. 1986;151:25–34. [PubMed: 3946748]

7.

Kahrilas P J, Dodds W J, Hogan W J. Effect of peristaltic dysfunction on esophageal volume clearance. Gastroenterology. 1988;94:73–80. [PubMed: 3335301]

8.

Helm J F, Dodds W J, Pelc L R, Palmer D W, Hogan W J, Teeter B C. Effect of esophageal emptying and saliva on clearance of acid from the esophagus. N Engl J Med. 1984;310:284–8. [PubMed: 6690951]

9.

Kahrilas P J, Dodds W J, Hogan W J, Kern M, Arndorfer R C, Reece A. Esophageal peristaltic dysfunction in peptic esophagitis. Gastroenterology. 1986;91:897–904. [PubMed: 3743966]

10.

Holloway R H, Hongo M, Berger K, McCallum R W. Gastric distention: a mechanism for postprandial gastroesophageal reflux. Gastroenterology. 1985;89:779–84. [PubMed: 4029557]

11.

Schwizer W, Hinder R A, DeMeester T R. Does delayed gastric emptying contribute to gastroesophageal reflux disease? Am J Surg. 1989;15:74–81. [PubMed: 2910130]

12.

Maddern G J, Jamieson G G, Chatterton B E, Collins P J. Is there an association between failed antireflux procedures and delayed gastric emptying? Ann Surg. 1985;202:162–5. [PMC free article: PMC1250869] [PubMed: 4015221]

13.

Barlow A P, DeMeester T R, Ball C S, Eypasch E P. The significance of the gastric secretory state in gastroesophageal reflux disease. Arch Surg. 1989;124:937–40. [PubMed: 2757507]

14.

Collen M J, Johnson D A, Sheridan M J. Basal acid output and gastric acid hypersecretion in gastroesophageal reflux disease. Correlation with ranitidine therapy. Dig Dis Sci. 1994;39:410–7. [PubMed: 8313826]

15.

Bremner R M, Crookes P F, DeMeester T R, Peters J H, Stein H J. Concentration of refluxed acid and esophageal mucosal injury. Am J Surg. 1992;164:522. [PubMed: 1443381]

16.

Koufman J, Sataloff RT, Toohill R. Laryngopharyngeal reflux: Consensus conference report. J Voice 1996; 215-216 . [PubMed: 8865091]

17.

Cameron A J, Zinsmeister A R, Ballard D J, Carney J A. Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology. 1990;99:918–22. [PubMed: 2394347]

18.

Johansson K E, Ask P, Boeryd B, Fransson S G, Tibbling L. Oesophagitis, signs of reflux, and gastric acid secretion in patients with symptoms of gastro-oesophageal reflux disease. Scand J Gastroenterol. 1986;21:837–47. [PubMed: 3775250]

19.

Johnson L F, DeMeester T R. Development of the 24-hour intraesophageal pH monitoring composite scoring system. J Clin Gastroenterol. 1986;8:52–8. [PubMed: 3734377]

20.

Jamieson JR, Stein HJ, DeMeester TR, et al. Ambulatory 24-H esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. 1992; 87: 1102–1111. [PubMed: 1519566]

21.

Campos GM, Peters JH, DeMeester TR, Oberg S, Crookes PF, Mason RJ The pattern of esophageal acid exposure in gastroesophageal reflux disease influences the severity of the disease. Arch Surg 1999;134: 882–7; discussion 887–8. [PubMed: 10443813]

22.

Zaninotto G, DeMeester T R, Schwizer W, Johansson K E, Cheng S C. The lower esophageal sphincter in health and disease. Am J Surg. 1988;155:104–11. [PubMed: 3341525]

23.

Dodds W J, Dent J, Hogan W J, Helm J F, Hauser R, Patel G K, Egide M S. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N Engl J Med. 1982;307:1547–52. [PubMed: 7144836]

24.

Zaninotto G, Costantini M, Bonavina L, Merigliano S, Baessato M, Iuliani M, Anselmino M, Ancona E. Manometric characteristics of the distal oesophageal sphincter and patterns of gastro-oesophageal reflux in healthy volunteers and patients. Eur Surg Res. 1987;19:217–24. [PubMed: 3609082]

25.

Richardson JD, Richardson RL. Collis-Nissen gastroplasty for shortened esophagus: longterm evaluation. Ann Surg 1998 May;227(5):735–40; discussion 740–2 . [PMC free article: PMC1191357] [PubMed: 9605665]

26.

Jobe B A, Horvath K D, Swanstrom L L. Postoperative function following laparoscopic Collis gastroplasty for foreshortened esophagus. Arch Surg. 1988;133:867–874. [PubMed: 9711961]

27.

Kauer W K H, Peters J H, DeMeester T R, Ireland A, Bremner C G, Hagen J A. Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphesized. Ann Surg. 1995;222:525–531. [PMC free article: PMC1234886] [PubMed: 7574932]

28.

Younes Z, Johnson D A. Diagnostic evaluation in gastroesophageal reflux disease. Gastroenterol Clin North Am. 1999;28:809–30. [PubMed: 10695003]

29.

Hetzel D J, Dent J, Reed W D. et al. Healing and relapse of severe peptic esophagitis after treatment with omeperazole. Gastroenterology. 1988;95:903–912. [PubMed: 3044912]

30.

Johansson K E, Ask P, Boeryd B, Fransson S G, Tibbling L. Oesophagitis, signs of reflux, and gastric acid secretion in patients with symptoms of gastro-oesophageal reflux disease. Scand J Gastroenterol. 1986 Sep;21(7):837–47. [PubMed: 3775250]

31.

Watson D I, Foreman D, Devitt P G, Jamieson G G. Preoperative endoscopic grading of esophagitis versus outcome after laparoscopic Nissen fundoplication. AJG. 1997;92:222–225. [PubMed: 9040195]

32.

DeMeester S R, DeMeester T R. Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy. Ann Surg. 2000;231:303–21. [PMC free article: PMC1421001] [PubMed: 10714623]

33.

Watson A. Barrett's oesophagus - 50 years on. Br J Surg. 2000;87:529–531. [PubMed: 10792304]

34.

Eisen G M, Sandler R S, Murray S, Gottfried M. The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus. Am J Gastroenterol. 1997;92:27–31. [PubMed: 8995932]

35.

Clark G W, Ireland A P, DeMeester T R. Dysplasia in Barrett's esophagus: diagnosis, surveillance and treatment. Dig Dis. 1996;14:213–27. [PubMed: 8843978]

36.

Stein U J, Hoeft S, DeMeester T R. Functional foregut abnormalities in Barrett's esophagus. J Thorac Cardiovasc Surg. 1993;105:107–11. [PubMed: 8419690]

37.

Singh P, Taylor R H, Colin-Jones D G. Esophageal motor dysfunction and acid exposure in reflux esophagitis are more severe if Barrett's metaplasia is present. Am J Gastroenterol. 1994;89:349–56. [PubMed: 8122643]

38.

Fein M, Ireland A P, Ritter M P, Peters J H, Hagen J A, Bremner C G, DeMeester T R. Duodenogastric Reflux Potentiates the Injurious Effects of Gastroesophageal Reflux. J Gastrointest Surg. 1997;1:27–33. [PubMed: 9834327]

39.

Kauer W K H, Peters J H, DeMeester T R, Ireland A, Bremner C G, Hagen J A. Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphesized. Ann Surg. 1995;222:525–531. [PMC free article: PMC1234886] [PubMed: 7574932]

40.

Farrell T M, Smith C D, Metreveli R E. et al. Fundoplication provides effective and durable symptom relief in patients with Barrett's esophagus. Am J Surg. 1999;178:18–21. [PubMed: 10456696]

41.

Katz D, Rothstein R, Schned A, Dunn J, Seaver K, Antonioli D. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus. Am J Gastroenterol. 1998;93:536–41. [PubMed: 9576444]

42.

Peghini P L, Katz P O, Bracy N A, Castell D O. Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors. Am J Gastroenterol. 1998;93:763–7. [PubMed: 9625124]

43.

Clark G W B, Ireland A P, Peters J H, Chandrasoma P, DeMeester T R, Bremner C G. Short-Segment Barrett's Esophagus: A Prevalent Complication of Gastroesophageal Reflux Disease With Malignant Potential. J Gastrointest Surg. 1997;1:113–122. [PubMed: 9834337]

44.

Richter J E. Peptic strictures of the esophagus. Gastroenterol Clin North Am. 1999;28:875–891. [PubMed: 10695007]

45.

Agnew S R, Pandya S P, Reynolds R P E, Preiksaitis H G. Predictors for frequent esophageal dilatation for benign peptic strictures. Dig Dis Sci. 1996;41:931–936. [PubMed: 8625765]

46.

Watson A. Reflux stricture of the esophagus. Br J Surg. 1987;74:443–448. [PubMed: 3300837]

47.

Klingler PJ, Hinder RA, Cina RA, DeVault KR, Floch NR, Branton SA, Seelig MH. Laparoscopic antireflux surgery for treatment of esophageal strictures refractory to medical therapy. Am J Gastroenterol 1999;(3):623–6 . [PubMed: 10086643]

48.

Spivak H, Farrell T M, Trus T L. et al. Laparoscopic fundoplication for dysphagia and peptic esophageal stricture. J Gastrointest Surg. 1998;2:555–560. [PubMed: 10458731]

49.

Reynolds J C, Waronker M, Pacquing M S, Yassin R R. Barrett's esophagus. Reducing the risk of progression to adenocarcinoma. Gastroenterol Clin North Am. 1999 Dec;28(4):917–45. [PubMed: 10695010]

50.

Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340:825–31. [PubMed: 10080844]

51.

DeMeester T R. Antireflux surgery in the management of Barrett's esophagus. J Gastrointest Surg. 2000;4:124–8. [PubMed: 10885957]

52.

Spechler S J. Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. The Department of Veteran Affairs Gastroesophageal Reflux Disease Study Group. N Eng J Med. 1992;326:786–792. [PubMed: 1538721]

53.

Klinkenberg-Knol E C, Nelis F, Dent J, Snel P, Mitchell B, Prichard P, Lloyd D, Havu N, Frame M H, Roman J, Walan A, Group L T. Long term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa. Gastroenterology. 2000;118:661–9. [PubMed: 10734017]

54.

Hetzel D J, Dent J, Reed W D, Narielvala F M, Mackinnon M, McCarthy J H, Mitchell B, Beveridge B R, Laurence B H, Gibson G G. et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology. 1988 Oct;95(4):903–12. [PubMed: 3044912]

55.

McDougall N I, Johnston B T, Kee F, Collins J S, McFarland R J, Love A H. Natural history of reflux esophagitis: a 10year follow up of its effect on patient symptomatology and quality of life. Gut. 1996;38:481–6. [PMC free article: PMC1383100] [PubMed: 8707073]

56.

Hinder R A, Libby J S, Gorecki P, Bammer T. Antireflux surgery. Indications, preoperative evaluation and outcome. Gastroenterol Clin North Am. 1999;28:987–1005. [PubMed: 10695013]

57.

Campos G M R, Peters J H, DeMeester T. et al. Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication. J Gastrointest Surg. 1999;3:292–300. [PubMed: 10481122]

58.

Ritter M P, Peters J H, DeMeester T R. et al. Outcome after laparoscopic fundoplication is not dependent on a structurally defective lower esophageal sphincter. J Gastrointest Surg. 1998;6:567–571. [PubMed: 10457315]

59.

Dodds W J, Dent J, Hogan W J, Helm J F, Hauser R, Patel G K, Egide M S. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N Engl J Med. 1982;307:1547–52. [PubMed: 7144836]

60.

Laine S, Rantala A, Gullichsen R, Ovaska J. Laparoscopic vs. conventional Nissen fundoplication. A prospective randomized study. Surg Endosc. 1997;11:441–444. [PubMed: 9153171]

61.

Bais J E, Bartelsman J F W M, Bonjer H J. et al. Laparoscopic or conventional Nissen fundoplication for gastroesophageal reflux disease; randomized clinical trial. Lancet. 2000;355:170–174. [PubMed: 10675115]

62.

Gorecki P J, Hinder R A. Correspondence - Gastro-oesophageal reflux disease. Lancet. 2000;356:70. [PubMed: 10892783]

63.

Perdikis G, Hinder R A, Lund R J. et al. Laparoscopic Nissen fundoplication: Where do we stand? Surg Laparosc Endosc. 1997;7:17–21. [PubMed: 9116940]

64.

Hinder R A, Filipi C J, Wetscher G. et al. Laparoscopic Nissen fundoplication is an effective treatment for gastroesophageal reflux disease. Ann Surg. 1994;220:472–483. [PMC free article: PMC1234418] [PubMed: 7944659]

65.

Hunter J G, Trus T L, Branum G D. et al. A physiologic approach to laparoscopic fundoplication for gastroesophageal reflux disease. Ann Surg. 1996;223:43–52. [PMC free article: PMC1235211] [PubMed: 8645041]

66.

Peters J H, DeMeester T R, Crookes P. et al. The treatment of gastroesophageal reflux disease with laparoscopic Nissen fundoplication. Ann Surg. 1998;228:40–50. [PMC free article: PMC1191426] [PubMed: 9671065]

67.

Rattner D W, Brooks D C. Patient satisfaction following laparoscopic and open anti-reflux surgery. Arch Surg. 1995;130:289–294. [PubMed: 7887796]

68.

Richardson W S, Hunter J G. Laparoscopic floppy Nissen fundoplication. Am J Surg. 1999;177:155–157. [PubMed: 10204561]

69.

Weerts J M, Dallemagne B, Hamoir E. et al. Laparoscopic Nissen fundoplication: Detailed analysis of 132 patients. Surg Laparosc Endosc. 1993;3:359–364. [PubMed: 8261262]

70.

DeMeester T R, Bonavina L, Albertucci M. Nissen fundoplication for gastroesophageal reflux disease. Evaluation of primary repair in 100 consecutive patients. Ann Surg. 1986;204:9–20. [PMC free article: PMC1251217] [PubMed: 3729589]

71.

Richardson W S, Hunter J G. Laparoscopic floppy Nissen fundoplication. Am J Surg. 1999;177:155–157. [PubMed: 10204561]

72.

Donahue P E, Samuelson S, Nyhus L M. et al. The floppy Nissen fundoplication: Effective long-term control of pathologic reflux. Arch Surg. 1985;120:663–668. [PubMed: 4004552]

73.

Richardson W S, Hunter J G. The “floppy” Nissen fundoplication is a completely competent antireflux valve. Surg Endosc. 1999;13:142–145. [PubMed: 9918616]

74.

Hunter J G, Swanstrom L, Waring J P. Dysphagia after laparoscopic antireflux surgery. The impact of operative technique. Ann Surg. 1996;224:51–57. [PMC free article: PMC1235246] [PubMed: 8678618]

75.

Watson D I, Pike G K, Baigre R J, Mathew G, Devitt P G, Britten-Jones R, Jamieson G G. Prospective double-blind randomized trial of laparoscopic Nissen fundoplication with division and without division of short gastric vessels. Ann Surg. 1997;226:642–652. [PMC free article: PMC1191126] [PubMed: 9389398]

76.

Watson D I, Baigrie R J, Jamieson G G. A Learning curve for laparoscopic fundoplication. Definable, avoidable or a waste of time? Ann Surg. 1996;224:198–203. [PMC free article: PMC1235342] [PubMed: 8757384]

77.

Champault G G, Barrat C, Rozon R C, Rizk N, Catheline J. The effect of the learning curve on the outcome of the laparoscopic treatment for gastroesophageal reflux. Surg Laparosc Endosc Percutan Tech. 1999;9:375–381. [PubMed: 10872617]

78.

Swanstrom L L. Partial fundoplications for gastroesophageal reflux disease. Indications and current status. J Clin Gastroenterol. 1999;29:127–132. [PubMed: 10478871]

79.

Wetscher G J, Glaser K, Wieschemeyer T. et al. Tailored antireflux surgery for gastroesophageal reflux disease: Effectiveness and risk of postoperative dysphagia. World J Surg. 1997;21:605–610. [PubMed: 9230657]

80.

Bell R C W, Hanna P, Mills M R, Bowrey D. Patterns of success and failure with laparoscopic Toupet fundoplication. Surg Endosc. 1999;13:1189–1194. [PubMed: 10594263]

81.

Richardson W S, Trus T L, Thompson S, Hunter J G. Nissen and Toupet fundoplications effectively inhibit gastroesophageal reflux irrespective of natural anatomy and function. Surg Endosc. 1997;11:261–3. [PubMed: 9079605]

82.

Horvath K D, Jobe B A, Herron D M, Swnstrom L L. Laparoscopic Toupet fundoplication is an inadequate procedure for patients with severe reflux disease. J Gastrointest Surg. 1999;3:583–591. [PubMed: 10554364]

83.

Farrell T M, Archer S B, Galloway K D. et al. Heartburn is more likely to recur after Toupet fundoplication than Nissen fundoplication. Am Surg. 2000;66:229–237. [PubMed: 10759191]

84.

Jobe B A, Wallace J, Hansen P D, Swanstrom L L. Evaluation of laparoscopic Toupet fundoplication as a primary repair for all patients with medically resistant gastroesophageal reflux. Surg Endosc. 1997;11:1080–1083. [PubMed: 9348378]

85.

Lund R F, Wetscher G F, Raiser F, Glaser K, Perdikis G, Gadenstatter M, Katada N, Filipi C J, Hinder R A. Laparoscopic Toupet fundoplication for gastroesophageal reflux disease with poor esophageal body motility. J Gastrointest Surg. 1997;1:301–308. [PubMed: 9834362]

86.

Gadenstatter M, Klingler A, Prommegger R, Hinder R A, Wetscher G J. Laparoscopic partial posterior fundoplication provides excellent intermediate results in GERD patients with impaired esophageal peristalsis. Surgery. 1999;126:548–52. [PubMed: 10486608]

87.

Hunter J G, Trus T L, Branum G D. et al. A physiologic approach to laparoscopic fundoplication for gastroesophageal reflux disease. Ann Surg. 1996;223:43–52. [PMC free article: PMC1235211] [PubMed: 8645041]

88.

Rydberg L, Ruth M, Abrahamsson H. et al. Tailoring antireflux surgery: a randomized clinical trial. World J Surg. 1999;23:612–618. [PubMed: 10227933]

89.

Walker S J, Holt S, Sanderson C J, Stoddard C J. Comparison of Nissen total and Lind partial transabdominal fundoplication in the treatment of gastro-esophageal reflux. Br J Surg. 1992;79:410–4. [PubMed: 1596721]

90.

Thor K B, Silander T. A long-term randomized prospective trial of the Nissen procedure versus a modified Toupet technique. Ann Surg. 1989;210:719–724. [PMC free article: PMC1357862] [PubMed: 2686567]

91.

Laws H L, Clements R H, Swillie C M. A randomized, prospective comparison of the Nissen fundoplication versus the Toupet fundoplication for gastroesophageal reflux disease. Ann Surg. 1997;225:647–654. [PMC free article: PMC1190862] [PubMed: 9230805]

92.

Kamolz T, Bammer T, Wykypiel H Jr, Pasiut M, Pointner R. Quality of Life and Surgical Outcome after Laparoscopic Nissen and Toupet Fundoplication: One-Year Follow-up. Endoscopy. 2000;32:363–368. [PubMed: 10817172]

Laparoscopic Nissen fundoplication is currently considered the surgical treatment of choice for gastroesophageal reflux disease (GERD) and its long-term effectiveness is above 90%. Adequate patient selection and the experience of the surgeon are among the predictive factors of good clinical response. However, there can be new, persistent, and recurrent symptoms after the antireflux procedure in up to 30% of the cases. There are numerous causes, but in general, they are due to one or more anatomic abnormalities and esophageal and gastric function alterations. When there are persistent symptoms after the surgical procedure, the surgery should be described as “failed”. In the case of a patient that initially manifests symptom control, but the symptoms then reappear, the term “dysfunction” could be used. When symptoms worsen, or when symptoms or clinical situations appear that did not exist before the surgery, this should be considered a “complication”. Postoperative dysphagia and dyspeptic symptoms are very frequent and require an integrated approach to determine the best possible treatment. This review details the pathophysiologic aspects, diagnostic approach, and treatment of the symptoms and complications after fundoplication for the management of GERD.

Categories: 1

0 Replies to “Case Study 9 Gerd Surgery”

Leave a comment

L'indirizzo email non verrà pubblicato. I campi obbligatori sono contrassegnati *